CDX2 and adenocarcinoma: Increased CDX2 expression, which is observed in approximately 90%–95% of colorectal adenocarcinomas [6, 7], is considered to be a highly sensitive and specific diagnostic marker for adenocarcinomas of intestinal origin [8–10].